Ouro Fino Saúde Animal Participações S.A. Stock

Equities

OFSA3

BROFSAACNOR7

Pharmaceuticals

Market Closed - Sao Paulo 04:05:00 2024-04-25 pm EDT 5-day change 1st Jan Change
21.71 BRL +0.05% Intraday chart for Ouro Fino Saúde Animal Participações S.A. -0.41% -16.53%
Sales 2024 * 1.11B 215M Sales 2025 * 1.2B 232M Capitalization 1.17B 226M
Net income 2024 * 101M 19.6M Net income 2025 * 112M 21.73M EV / Sales 2024 * 1.17 x
Net Debt 2024 * 134M 26.09M Net Debt 2025 * 151M 29.38M EV / Sales 2025 * 1.1 x
P/E ratio 2024 *
11.6 x
P/E ratio 2025 *
10.5 x
Employees 1,202
Yield 2024 *
3.82%
Yield 2025 *
6.55%
Free-Float 14.26%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Ouro Fino Saúde Animal Participações S.A., Q4 2023 Earnings Call, Mar 08, 2024
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Ouro Fino Saúde Animal Participações S.A., Q3 2023 Earnings Call, Nov 10, 2023
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Ouro Fino Saúde Animal Participações S.A., Q2 2023 Earnings Call, Aug 11, 2023
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Ouro Fino Saúde Animal Participações S.A., Q1 2023 Earnings Call, May 12, 2023
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Ouro Fino Saúde Animal Participações S.A. - Analyst/Investor Day
Transcript : Ouro Fino Saúde Animal Participações S.A., Q4 2022 Earnings Call, Mar 03, 2023
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : Ouro Fino Sa·de Animal Participat)es S.A., Q3 2022 Earnings Call, Nov 11, 2022
Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news

Latest transcript on Ouro Fino Saúde Animal Participações S.A.

1 day+0.05%
1 week-0.41%
Current month-13.16%
1 month-12.74%
3 months-6.42%
6 months+9.32%
Current year-16.53%
More quotes
1 week
21.52
Extreme 21.52
22.35
1 month
21.52
Extreme 21.52
25.45
Current year
20.75
Extreme 20.75
27.72
1 year
18.20
Extreme 18.2
27.72
3 years
18.20
Extreme 18.2
39.79
5 years
14.99
Extreme 14.99
45.10
10 years
14.99
Extreme 14.99
46.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 16-06-26
Founder 67 86-12-31
Director of Finance/CFO 45 20-03-31
Members of the board TitleAgeSince
Founder 67 86-12-31
Director/Board Member 62 17-04-24
Founder 69 86-12-31
More insiders
Date Price Change Volume
24-04-25 21.71 +0.05% 9,500
24-04-24 21.7 0.00% 27,000
24-04-23 21.7 0.00% 21,800
24-04-22 21.7 0.00% 4,500
24-04-19 21.7 -0.46% 17,800

Delayed Quote Sao Paulo, April 25, 2024 at 04:05 pm EDT

More quotes
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
21.71 BRL
Average target price
23.5 BRL
Spread / Average Target
+8.25%
Consensus